Published in Eur J Neurosci on October 01, 2003
Corticotropin-releasing factor increases mouse ventral tegmental area dopamine neuron firing through a protein kinase C-dependent enhancement of Ih. J Physiol (2008) 2.02
Leptin excites proopiomelanocortin neurons via activation of TRPC channels. J Neurosci (2010) 1.63
TRPC3 channels are necessary for brain-derived neurotrophic factor to activate a nonselective cationic current and to induce dendritic spine formation. J Neurosci (2007) 1.56
Progressive degeneration of dopaminergic neurons through TRP channel-induced cell death. J Neurosci (2014) 1.43
mGluR1/5 subtype-specific calcium signalling and induction of long-term potentiation in rat hippocampal oriens/alveus interneurones. J Physiol (2006) 1.23
mGluR-dependent persistent firing in entorhinal cortex layer III neurons. Eur J Neurosci (2008) 1.19
In utero exposure to cocaine delays postnatal synaptic maturation of glutamatergic transmission in the VTA. Nat Neurosci (2011) 1.09
Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms. Neuroscience (2011) 1.05
Invertebrate TRP proteins as functional models for mammalian channels. Pflugers Arch (2004) 1.05
Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. Int Rev Neurobiol (2010) 1.05
Non-selective cation channels, transient receptor potential channels and ischemic stroke. Biochim Biophys Acta (2007) 1.03
Dual signaling is differentially activated by different active states of the metabotropic glutamate receptor 1alpha. Proc Natl Acad Sci U S A (2006) 1.03
Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome. Pharmacol Ther (2006) 1.03
Bidirectional Hebbian plasticity at hippocampal mossy fiber synapses on CA3 interneurons. J Neurosci (2008) 1.01
Calcium-activated non-selective cation currents are involved in generation of tonic and bursting activity in dopamine neurons of the substantia nigra pars compacta. J Physiol (2011) 0.99
TRPC channels and diacylglycerol dependent calcium signaling in rat sensory neurons. Histochem Cell Biol (2008) 0.97
TRPC channels and their implication in neurological diseases. CNS Neurol Disord Drug Targets (2010) 0.97
A TRPC5-regulated calcium signaling pathway controls dendrite patterning in the mammalian brain. Genes Dev (2011) 0.96
2-Aminoethoxydiphenyl borate as a common activator of TRPV1, TRPV2, and TRPV3 channels. Handb Exp Pharmacol (2007) 0.92
The role of spiking and bursting pacemakers in the neuronal control of breathing. J Biol Phys (2011) 0.91
Previous ethanol experience enhances synaptic plasticity of NMDA receptors in the ventral tegmental area. J Neurosci (2011) 0.91
The cellular building blocks of breathing. Compr Physiol (2012) 0.91
Nonselective cation channels are essential for maintaining intracellular Ca2+ levels and spontaneous firing activity in the midbrain dopamine neurons. Pflugers Arch (2007) 0.90
Group I mGluR activation enhances Ca(2+)-dependent nonselective cation currents and rhythmic bursting in main olfactory bulb external tufted cells. J Neurosci (2009) 0.90
Transient receptor potential-like channels mediate metabotropic glutamate receptor EPSCs in rat dopamine neurones. J Physiol (2004) 0.90
Metabotropic glutamate receptors in the lateral superior olive activate TRP-like channels: age- and experience-dependent regulation. J Neurophysiol (2007) 0.87
Emerging roles of canonical TRP channels in neuronal function. Adv Exp Med Biol (2011) 0.87
A store-operated Ca(2+) influx pathway in the bag cell neurons of Aplysia. J Neurophysiol (2006) 0.86
BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons. J Neurosci (2015) 0.86
Danger- and pathogen-associated molecular patterns recognition by pattern-recognition receptors and ion channels of the transient receptor potential family triggers the inflammasome activation in immune cells and sensory neurons. J Neuroinflammation (2015) 0.83
Cholinergic receptor activation supports persistent firing in layer III neurons in the medial entorhinal cortex. Behav Brain Res (2013) 0.83
Expression of transient receptor potential (TRP) channel mRNAs in the mouse olfactory bulb. Neurosci Lett (2012) 0.81
Cocaine Decreases Metabotropic Glutamate Receptor mGluR1 Currents in Dopamine Neurons by Activating mGluR5. Neuropsychopharmacology (2015) 0.78
Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. Mol Psychiatry (2014) 0.76
mGluR1-mediated excitation of cerebellar GABAergic interneurons requires both G protein-dependent and Src-ERK1/2-dependent signaling pathways. PLoS One (2014) 0.76
Calcium Release from Stores Inhibits GIRK. Cell Rep (2016) 0.76
Differential Contribution of Ca(2+)-Dependent Mechanisms to Hyperexcitability in Layer V Neurons of the Medial Entorhinal Cortex. Front Cell Neurosci (2017) 0.75
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood (2007) 6.03
Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2008) 5.37
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron (2005) 3.30
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci (2003) 3.25
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci (2008) 2.87
An isochore map of human chromosomes. Genome Res (2006) 2.36
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95
Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci U S A (2004) 1.79
Cytosine methylation and CpG, TpG (CpA) and TpA frequencies. Gene (2004) 1.78
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci (2003) 1.66
Genomic GC level, optimal growth temperature, and genome size in prokaryotes. Biochem Biophys Res Commun (2006) 1.61
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Eur J Neurosci (2009) 1.59
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci (2009) 1.59
Interleukin-1β causes anxiety by interacting with the endocannabinoid system. J Neurosci (2012) 1.55
Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol (2003) 1.55
TNF-α-mediated anxiety in a mouse model of multiple sclerosis. Exp Neurol (2012) 1.55
Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease. PLoS One (2013) 1.50
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome. Biol Psychiatry (2007) 1.48
Correlations between genomic GC levels and optimal growth temperatures in prokaryotes. FEBS Lett (2004) 1.48
SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain (2010) 1.45
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter. Eur J Neurosci (2011) 1.45
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci (2003) 1.41
Microelectrode array recordings of cultured hippocampal networks reveal a simple model for transcription and protein synthesis-dependent plasticity. J Physiol (2004) 1.41
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci (2002) 1.40
Unilateral spatial neglect and alien limb phenomenon may be early features of Creutzfeldt-Jakob disease. Parkinsonism Relat Disord (2012) 1.39
The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? Trends Pharmacol Sci (2003) 1.39
The evolution of isochore patterns in vertebrate genomes. BMC Genomics (2009) 1.38
Dopamine excites fast-spiking interneurons in the striatum. J Neurophysiol (2002) 1.36
Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. PLoS One (2010) 1.36
Synaptic activity induces dramatic changes in the geometry of the cell nucleus: interplay between nuclear structure, histone H3 phosphorylation, and nuclear calcium signaling. J Neurosci (2009) 1.36
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain (2009) 1.35
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci (2006) 1.34
Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest (2012) 1.32
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity. J Neurosci (2003) 1.31
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors. J Pharmacol Exp Ther (2010) 1.30
Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci (2009) 1.27
FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood (2004) 1.27
Localization of the gene-richest and the gene-poorest isochores in the interphase nuclei of mammals and birds. Gene (2002) 1.27
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann Neurol (2003) 1.26
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Mov Disord (2005) 1.26
The endocannabinoid system in targeting inflammatory neurodegenerative diseases. Trends Pharmacol Sci (2007) 1.23
Replication timing, chromosomal bands, and isochores. Proc Natl Acad Sci U S A (2008) 1.22
Identification and enrichment of spermatogonial stem cells displaying side-population phenotype in immature mouse testis. FASEB J (2003) 1.22
Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Ann Neurol (2011) 1.19
Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium. Autophagy (2008) 1.19
Representing GC variation along eukaryotic chromosomes. Gene (2004) 1.18
Effects of anodal transcranial direct current stimulation on chronic neuropathic pain in patients with multiple sclerosis. J Pain (2009) 1.18
The new genes of rice: a closer look. Trends Plant Sci (2004) 1.17
Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett (2003) 1.17
P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab (2006) 1.16
Voltage-dependent membrane potential oscillations of rat striatal fast-spiking interneurons. J Physiol (2003) 1.15
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog Neurobiol (2004) 1.15
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. J Neurosci (2011) 1.14
Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J Comp Neurol (2002) 1.14
Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J (2004) 1.14
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology (2010) 1.14
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology (2006) 1.14
The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy? Trends Pharmacol Sci (2005) 1.13
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology (2004) 1.13
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. J Neurosci (2004) 1.13
Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors. Neuropsychopharmacology (2002) 1.13
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia. Neurobiol Dis (2009) 1.12
Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics (2006) 1.11
Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease. PLoS One (2010) 1.11
Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology (2005) 1.10
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. J Neurosci (2010) 1.10
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology (2002) 1.10
Synaptic plasticity in the ischaemic brain. Lancet Neurol (2003) 1.09
Endogenous serotonin excites striatal cholinergic interneurons via the activation of 5-HT 2C, 5-HT6, and 5-HT7 serotonin receptors: implications for extrapyramidal side effects of serotonin reuptake inhibitors. Neuropsychopharmacology (2007) 1.09
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2008) 1.09
TRPV1 channels facilitate glutamate transmission in the striatum. Mol Cell Neurosci (2008) 1.08
Diffusion and not active transport underlies and limits ERK1/2 synapse-to-nucleus signaling in hippocampal neurons. J Biol Chem (2007) 1.07
Effects of epilepsy treatment on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia (2014) 1.07
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci (2004) 1.06
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity. Rev Neurosci (2003) 1.06
Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene. Clin Neurol Neurosurg (2010) 1.06
Isochore pattern and gene distribution in the chicken genome. Gene (2007) 1.06
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol (2012) 1.05
Characterization of human Enah gene. Biochim Biophys Acta (2006) 1.05
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. Brain (2010) 1.05
Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration. J Neurochem (2006) 1.04
Isochore patterns and gene distributions in fish genomes. Genomics (2007) 1.04
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. Mult Scler (2010) 1.04
The short-sequence designs of isochores from the human genome. Proc Natl Acad Sci U S A (2008) 1.03
Temperature sensitivity of dopaminergic neurons of the substantia nigra pars compacta: involvement of transient receptor potential channels. J Neurophysiol (2005) 1.03
Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J Neurosci (2008) 1.02
Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav Immun (2010) 1.02
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum. Eur J Neurosci (2002) 1.02
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurol Sci (2009) 1.02